Patents by Inventor James C. Mannion

James C. Mannion has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20150374706
    Abstract: The present invention includes compositions that are useful in the treatment of breathing control diseases or disorders in a subject in need thereof. The present invention also includes a method of treating a respiratory disease or disorder in a subject in need thereof, comprising administering to the subject a therapeutically effective amount of a pharmaceutical formulation of the invention. The present invention further includes a method of preventing destabilization or stabilizing breathing rhythm in a subject in need thereof, comprising administering to the subject a therapeutically effective amount of a pharmaceutical formulation of the invention.
    Type: Application
    Filed: September 11, 2015
    Publication date: December 31, 2015
    Inventors: JAMES C. MANNION, SCOTT L. DAX, DUNCAN EUAN MACINTYRE, FRANCIS JOHN GOLDER, JAMES FRANCIS MCLEOD
  • Patent number: 9162992
    Abstract: The present invention includes compounds, and compositions comprising the same, that are useful in the treatment of breathing control diseases or disorders in a subject in need thereof. The present invention also includes a method of treating a respiratory disease or disorder in a subject in need thereof, comprising administering to the subject a therapeutically effective amount of a compound of the invention. The present invention further includes a method of preventing destabilization or stabilizing breathing rhythm in a subject in need thereof, comprising administering to the subject a therapeutically effective amount of a compound of the invention.
    Type: Grant
    Filed: August 29, 2014
    Date of Patent: October 20, 2015
    Assignee: Galleon Pharmaceuticals, Inc.
    Inventors: James C. Mannion, Scott L. Dax, Duncan Euan MacIntyre, Francis John Golder, James Francis McLeod
  • Publication number: 20150291597
    Abstract: The present invention includes compositions that are useful in the prevention and/or treatment of breathing control diseases or disorders in a subject in need thereof. The present invention also includes a method of preventing and/or treating a respiratory disease or disorder in a subject in need thereof, comprising administering to the subject a therapeutically effective amount of a composition of the invention. The present invention further includes a method of preventing destabilization or stabilizing breathing rhythm in a subject in need thereof, comprising administering to the subject a therapeutically effective amount of a composition of the invention.
    Type: Application
    Filed: November 14, 2013
    Publication date: October 15, 2015
    Inventors: James C. Mannion, Scott L. Dax, Francis John Golder, Duncan Euan MacIntyre, James McLeod, Vita Ozola, Edgars Suna, Kirill Shubin, James Joseph Mencel, Sean X. Peng
  • Patent number: 9102636
    Abstract: The invention relates to compounds, compositions, and methods for diminishing pain in a subject in need thereof comprising administering the compounds and compositions herein described.
    Type: Grant
    Filed: March 8, 2011
    Date of Patent: August 11, 2015
    Assignee: Galleon Pharmaceuticals, Inc.
    Inventors: James C. Mannion, Scott L. Dax
  • Publication number: 20140371224
    Abstract: The present invention includes compounds, and compositions comprising the same, that are useful in the treatment of breathing control diseases or disorders in a subject in need thereof. The present invention also includes a method of treating a respiratory disease or disorder in a subject in need thereof, comprising administering to the subject a therapeutically effective amount of a compound of the invention. The present invention further includes a method of preventing destabilization or stabilizing breathing rhythm in a subject in need thereof, comprising administering to the subject a therapeutically effective amount of a compound of the invention.
    Type: Application
    Filed: August 29, 2014
    Publication date: December 18, 2014
    Inventors: JAMES C. MANNION, SCOTT L. DAX, DUNCAN EUAN MACINTYRE, FRANCIS JOHN GOLDER, JAMES FRANCIS MCLEOD
  • Publication number: 20120295911
    Abstract: The present invention includes compositions that are useful in the treatment of breathing control diseases or disorders in a subject in need thereof. The present invention also includes a method of treating a respiratory disease or disorder in a subject in need thereof, comprising administering to the subject a therapeutically effective amount of a pharmaceutical formulation of the invention. The present invention further includes a method of preventing destabilization or stabilizing breathing rhythm in a subject in need thereof, comprising administering to the subject a therapeutically effective amount of a pharmaceutical formulation of the invention.
    Type: Application
    Filed: May 29, 2012
    Publication date: November 22, 2012
    Inventors: James C. Mannion, Scott L. Dax, Duncan Euan MacIntyre, Francis John Golder, James Francis McLeod
  • Publication number: 20120270848
    Abstract: The present invention includes compositions and methods for treating a subject in need of opioid therapy, wherein the opioid therapy produces or has the possibility of producing respiratory depression or a breathing control disorder in the subject.
    Type: Application
    Filed: April 20, 2012
    Publication date: October 25, 2012
    Inventors: James C. Mannion, Scott L. Dax
  • Publication number: 20120101073
    Abstract: The present invention includes a method of treating a respiratory disease or disorder in a subject in need thereof, comprising administering to the subject a therapeutically effective amount of a pharmaceutical formulation comprising (+)-doxapram or a salt thereof, and a pharmaceutically acceptable carrier, wherein the formulation is essentially free of (?)-doxapram or a salt thereof.
    Type: Application
    Filed: October 22, 2010
    Publication date: April 26, 2012
    Inventors: James C. Mannion, Scott L. Dax, Richard Woodward
  • Publication number: 20110224269
    Abstract: The invention relates to compounds, compositions, and methods for diminishing pain in a subject in need thereof comprising administering the compounds and compositions herein described.
    Type: Application
    Filed: March 8, 2011
    Publication date: September 15, 2011
    Inventors: James C. Mannion, Scott L. Dax
  • Publication number: 20100105685
    Abstract: The present invention is directed to a method of treating a lack of normal breathing control including the treatment of apnea and hypoventilation associated with sleep, obesity, certain medicines and other medical conditions. In an aspect, the invention is directed to treating disordered control of breathing by administering an composition comprising a single compound which treats lack of normal breathing. In another aspect, the invention is directed to treating disordered control of breathing by administering an composition comprising a combination of two or more compounds, at least one of which treats lack of normal breathing. In an aspect, a compound is an S-nitrosylating agent.
    Type: Application
    Filed: October 3, 2007
    Publication date: April 29, 2010
    Inventor: James C. Mannion
  • Publication number: 20100035998
    Abstract: The present invention is directed to a method of treating a lack of normal breathing control including the treatment of apnea and hypoventilation associated with sleep, obesity, certain medicines and other medical conditions. In an aspect, the invention is directed to treating disordered control of breathing by administering an composition comprising a combination of two or more compounds, at least one of which treats lack of normal breathing. In one aspect, a compound is an S-nitrosylating agent.
    Type: Application
    Filed: September 20, 2006
    Publication date: February 11, 2010
    Applicant: Galleon Pharmaceutical, Inc
    Inventor: James C. Mannion